RNXT Insider Trading
Insider Ownership Percentage: 9.40%
Insider Buying (Last 12 Months): $89,293.85
Insider Selling (Last 12 Months): $0.00
RenovoRx Share Price & Price History
Current Price: $1.12
Price Change: ▼ Price Decrease of -0.03 (-2.61%)
As of 08/7/2026 04:00 PM ET
RenovoRx Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/19/2026 | Mark Voll | CFO | Buy | 25,000 | $0.79 | $19,750.00 | 142,380 | |
| 1/21/2026 | Ramtin Agah | Insider | Buy | 10,000 | $1.00 | $10,000.00 | 798,460 | |
| 12/31/2025 | Ramtin Agah | Insider | Buy | 9,795 | $0.86 | $8,423.70 | 788,460 | |
| 12/30/2025 | Ramtin Agah | Insider | Buy | 205 | $0.83 | $170.15 | 778,665 | |
| 12/17/2025 | Shaun Bagai | CEO | Buy | 5,000 | $0.85 | $4,250.00 | 340,040 | |
| 12/16/2025 | Ramtin Agah | Insider | Buy | 12,000 | $0.85 | $10,200.00 | 778,460 | |
| 12/5/2025 | Ramtin Agah | Insider | Buy | 10,000 | $0.96 | $9,600.00 | 766,460 | |
| 11/24/2025 | Ramtin Agah | Insider | Buy | 12,000 | $0.80 | $9,600.00 | 756,460 | |
| 11/21/2025 | Ramtin Agah | Insider | Buy | 10,000 | $0.80 | $8,000.00 | 744,460 | |
| 8/25/2025 | Shaun Bagai | CEO | Buy | 5,000 | $0.91 | $4,550.00 | 330,040 | |
| 8/22/2025 | Shaun Bagai | CEO | Buy | 5,000 | $0.95 | $4,750.00 | 325,040 | |
| 6/5/2025 | Ramtin Agah | Insider | Buy | 21,000 | $1.40 | $29,400.00 | 734,460 | |
| 4/15/2025 | Ramtin Agah | Insider | Buy | 15,000 | $0.90 | $13,500.00 | 1,113,460 | |
| 4/15/2025 | Shaun Bagai | CEO | Buy | 7,500 | $0.91 | $6,825.00 | 320,040 | |
| 4/11/2025 | Ramtin Agah | Insider | Buy | 20,000 | $0.80 | $16,000.00 | 1,098,460 | |
| 4/10/2025 | Ron Kocak | VP | Buy | 6,500 | $0.79 | $5,135.00 | 12,595 | |
| 4/9/2025 | Shaun Bagai | CEO | Buy | 10,000 | $0.83 | $8,300.00 | 312,540 | |
| 4/8/2025 | Laurence Marton | Director | Buy | 12,050 | $0.85 | $10,242.50 | 45,684 | |
| 4/8/2025 | Ramtin Agah | Insider | Buy | 26,000 | $0.84 | $21,840.00 | 1,048,460 | |
| 4/8/2025 | Ron Kocak | VP | Buy | 95 | $0.80 | $76.00 | 95 | |
| 4/7/2025 | Shaun Bagai | CEO | Buy | 10,000 | $0.83 | $8,300.00 | 302,540 | |
| 10/3/2023 | Angela Nelms | COO | Buy | 1,100 | $1.05 | $1,155.00 | 1,100 | |
RenovoRx Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 4/30/2026 | AIGH Capital Management LLC | 3,706,197 | $3.68M | 0.5% | +30.8% | 8.227% |  |
| 2/18/2026 | XTX Topco Ltd | 50,140 | $42K | 0.0% | +58.6% | 0.137% |  |
| 2/13/2026 | Bleichroeder LP | 600,000 | $0.50M | 0.1% | +11.4% | 1.637% |  |
| 2/13/2026 | Wealthspire Advisors LLC | 252,525 | $0.21M | 0.0% | N/A | 0.689% |  |
| 2/12/2026 | Renaissance Technologies LLC | 117,457 | $99K | 0.0% | -62.5% | 0.320% |  |
| 2/2/2026 | AIGH Capital Management LLC | 2,833,894 | $2.38M | 0.6% | +8.4% | 7.732% |  |
| 11/17/2025 | Citadel Advisors LLC | 121,341 | $0.15M | 0.0% | N/A | 0.331% |  |
| 11/7/2025 | Vanguard Group Inc. | 1,605,079 | $2.04M | 0.0% | -3.5% | 4.380% |  |
| 10/31/2025 | AIGH Capital Management LLC | 2,615,193 | $3.32M | 0.9% | -24.6% | 7.136% |  |
| 8/15/2025 | AWM Investment Company Inc. | 1,870,225 | $2.47M | 0.3% | -18.2% | 5.114% |  |
| 8/13/2025 | Northwestern Mutual Wealth Management Co. | 74,596 | $98K | 0.0% | N/A | 0.204% |  |
| 8/13/2025 | Corsair Capital Management L.P. | 95,373 | $0.13M | 0.0% | -49.2% | 0.261% |  |
| 8/8/2025 | Geode Capital Management LLC | 353,603 | $0.47M | 0.0% | +9.9% | 0.967% |  |
| 5/16/2025 | AWM Investment Company Inc. | 2,285,000 | $2.26M | 0.3% | N/A | 6.251% |  |
| 5/16/2025 | Alyeska Investment Group L.P. | 688,577 | $0.68M | 0.0% | N/A | 1.884% |  |
| 5/16/2025 | ADAR1 Capital Management LLC | 479,883 | $0.48M | 0.1% | +143.3% | 1.313% |  |
| 5/15/2025 | Corsair Capital Management L.P. | 187,700 | $0.19M | 0.0% | N/A | 0.514% |  |
| 5/14/2025 | Stonepine Capital Management LLC | 278,188 | $0.28M | 0.3% | N/A | 0.761% |  |
| 5/13/2025 | HighTower Advisors LLC | 40,000 | $40K | 0.0% | N/A | 0.109% |  |
| 5/9/2025 | Chicago Partners Investment Group LLC | 92,356 | $97K | 0.0% | N/A | 0.253% |  |
| 5/6/2025 | AIGH Capital Management LLC | 3,467,275 | $3.43M | 1.4% | N/A | 9.486% |  |
| 2/17/2025 | Citadel Advisors LLC | 37,757 | $49K | 0.0% | N/A | 0.157% |  |
| 2/13/2025 | Renaissance Technologies LLC | 64,900 | $84K | 0.0% | N/A | 0.270% |  |
| 2/13/2025 | ADAR1 Capital Management LLC | 197,250 | $0.25M | 0.1% | -37.4% | 0.822% |  |
| 11/16/2024 | Geode Capital Management LLC | 232,937 | $0.25M | 0.0% | +61.9% | 0.971% |  |
| 2/9/2024 | Nixon Peabody Trust Co. | 97,165 | $0.22M | 0.0% | N/A | 0.909% |  |
| 7/10/2023 | Level Four Advisory Services LLC | 15,000 | $34K | 0.0% | +50.0% | 0.148% |  |
| 6/5/2023 | Level Four Advisory Services LLC | 10,000 | $35K | 0.0% | N/A | 0.099% |  |
| 1/19/2023 | Affinity Capital Advisors LLC | 15,259 | $36K | 0.0% | +35.6% | 0.168% |  |
| 11/10/2022 | Cohen Lawrence B | 54,121 | $0.16M | 0.1% | -44.3% | 0.597% |  |
| 8/11/2022 | Cohen Lawrence B | 97,165 | $0.19M | 0.1% | +79.5% | 1.072% |  |
| 8/2/2022 | Bank of The West | 975,000 | $1.93M | 0.2% | N/A | 10.750% |  |
| 5/13/2022 | Cohen Lawrence B | 54,121 | $0.16M | 0.1% | N/A | 0.599% |  |
Data available starting January 2016
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
Read More on RenovoRx
Volume
317,826 shs
Average Volume
260,187 shs
Market Capitalization
$50.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.99
Who are the company insiders with the largest holdings of RenovoRx?